Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 13, 2022
Share
Easywell Biomedicals, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 35.07 million compared to TWD 71.64 million a year ago. Net loss was TWD 52.18 million compared to net income of TWD 5.06 million a year ago. Basic loss per share from continuing operations was TWD 0.32 compared to basic earnings per share from continuing operations of TWD 0.04 a year ago. Basic loss per share was TWD 0.32 compared to basic earnings per share of TWD 0.04 a year ago.
Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.